Medication info
Candesa Plus Tablets

Candesa Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Light pink, oval-shaped tablets with a biconvex surface.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200905876 · Notified 2009.07.24 · Insurance code 663603050

Summary

Main use
Treatment of essential hypertension not controlled with a single ingredient
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, first adjust the dose of candesartan cilexetil. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with a single ingredient

  • Essential hypertension
View approved original text

Essential hypertension may not be adequately treated with individual components, so this medication helps effectively control blood pressure by acting through multiple ingredients. It is used to improve hypertension by dilating blood vessels and reducing the burden on the heart.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, first adjust the dose of candesartan cilexetil. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medicine can cause serious harm to the fetus and newborn, especially in the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any ingredient in this medication or to sulfonamide class drugs should not use it. Those with severe kidney or liver impairment, a history of angioedema, or specific conditions like gout should avoid taking this medication. Patients with electrolyte imbalances or a risk of hypotension should consult healthcare professionals before taking this medication and use it with caution. As this medication lowers blood pressure, care should be taken due to the risk of dizziness or fainting from sudden blood pressure drops. Long-term use may increase the risk of skin cancer, so it is important to minimize sun exposure and immediately report any skin abnormalities to healthcare professionals. Regular monitoring of kidney function and electrolyte levels through blood tests is necessary during the use of this medication. Since interactions can occur when taking this medication with other antihypertensives, diuretics, or potassium supplements, it is essential to inform healthcare providers of any other medications being taken. This drug may be excreted in breast milk, so breastfeeding mothers should consult their doctor before deciding to use it. Elderly patients should use this drug cautiously, as there is a potential for excessively low blood pressure, which could lead to heart or brain function issues. In case of overdose, symptoms like hypotension, dizziness, and electrolyte imbalances may occur; immediate medical care should be sought, and appropriate treatment should be received in emergencies. This medication has not been established as safe and effective for use in children and adolescents, so it is advisable not to use it in this population. When storing, keep out of reach of children and store in the original container to protect its quality. When driving or operating machinery, dizziness or fatigue may occasionally occur, so caution is recommended if symptoms are present.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory infections
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infections
  • nausea
  • contusions
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dizziness
  • intestinal edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • sensory abnormalities
  • transient visual disturbances
  • choroidal effusion
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • loss of appetite
  • appetite loss
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reactions
  • toxic epidermal necrolysis
  • skin erythematous lupus-like reaction
  • activation of skin erythematous lupus
  • muscle spasms
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reactions
  • jaundice
  • sleep disorders
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture, preferably at a cool temperature below 30 degrees Celsius. It is important to avoid direct sunlight and not to place it in excessively hot conditions.

Appearance and packaging

Appearance

Light pink, oval-shaped tablets with a biconvex surface.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.